IDEXX LABORATORIES INC /DE Interest Expense
IDEXX LABORATORIES INC /DE (IDXX) reported Interest Expense of $7.91 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-01.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-01
- IDEXX LABORATORIES INC /DE interest expense for the quarter ending 2024-03-31 was $7.91M, a 39.73% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest expense for the quarter ending 2023-12-31 was $9.27M, a 31.61% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest expense for the quarter ending 2023-09-30 was $8.65M, a 21.38% decline year-over-year.
- IDEXX LABORATORIES INC /DE interest expense for the quarter ending 2023-06-30 was $10.54M, a 26.75% increase year-over-year.
- IDEXX LABORATORIES INC /DE interest expense for fiscal 2023 was $41.58M, a 4.32% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE interest expense for fiscal 2022 was $39.86M, a 33.72% increase from fiscal 2021.
- IDEXX LABORATORIES INC /DE interest expense for fiscal 2021 was $29.81M, a 10.01% decline from fiscal 2020.
- IDEXX LABORATORIES INC /DE interest expense for fiscal 2020 was $33.13M, a 6.67% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $7.91M 10-Q · filed 2024-05-01 | $17.18M derived: sum of 2 quarters · filed 2024-05-01 | $25.82M derived: sum of 3 quarters · filed 2024-05-01 | $36.37M derived: sum of 4 quarters · filed 2024-05-01 |
| 2023-12-31 | $9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $17.91M derived: sum of 2 quarters · filed 2024-02-22 | $28.45M derived: sum of 3 quarters · filed 2024-02-22 | $41.58M 10-K · filed 2024-02-22 |
| 2023-09-30 | $8.65M 10-Q · filed 2023-11-01 | $19.19M derived: sum of 2 quarters · filed 2023-11-01 | $32.32M 10-Q · filed 2023-11-01 | $45.86M derived: sum of 4 quarters · filed 2024-05-01 |
| 2023-06-30 | $10.54M 10-Q · filed 2023-08-01 | $23.67M 10-Q · filed 2023-08-01 | $37.22M derived: sum of 3 quarters · filed 2024-05-01 | $48.21M derived: sum of 4 quarters · filed 2024-05-01 |
| 2023-03-31 | $13.13M 10-Q · filed 2024-05-01 | $26.67M derived: sum of 2 quarters · filed 2024-05-01 | $37.67M derived: sum of 3 quarters · filed 2024-05-01 | $45.99M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $24.55M derived: sum of 2 quarters · filed 2024-02-22 | $32.86M derived: sum of 3 quarters · filed 2024-02-22 | $39.86M 10-K · filed 2024-02-22 |
| 2022-09-30 | $11.00M 10-Q · filed 2023-11-01 | $19.32M derived: sum of 2 quarters · filed 2023-11-01 | $26.31M 10-Q · filed 2023-11-01 | $33.79M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $8.32M 10-Q · filed 2023-08-01 | $15.31M 10-Q · filed 2023-08-01 | $22.79M derived: sum of 3 quarters · filed 2024-02-22 | $29.92M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $7.00M 10-Q · filed 2023-05-02 | $14.47M derived: sum of 2 quarters · filed 2024-02-22 | $21.61M derived: sum of 3 quarters · filed 2024-02-22 | $29.22M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $14.61M derived: sum of 2 quarters · filed 2024-02-22 | $22.22M derived: sum of 3 quarters · filed 2024-02-22 | $29.81M 10-K · filed 2024-02-22 |
| 2021-09-30 | $7.13M 10-Q · filed 2022-11-01 | $14.75M derived: sum of 2 quarters · filed 2022-11-01 | $22.33M 10-Q · filed 2022-11-01 | $30.16M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $7.61M 10-Q · filed 2022-08-02 | $15.20M 10-Q · filed 2022-08-02 | $23.02M derived: sum of 3 quarters · filed 2023-02-16 | $31.14M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $7.58M 10-Q · filed 2022-05-04 | $15.41M derived: sum of 2 quarters · filed 2023-02-16 | $23.52M derived: sum of 3 quarters · filed 2023-02-16 | $33.02M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $15.94M derived: sum of 2 quarters · filed 2023-02-16 | $25.43M derived: sum of 3 quarters · filed 2023-02-16 | $33.13M 10-K · filed 2023-02-16 |
| 2020-09-30 | $8.11M 10-Q · filed 2021-11-02 | $17.61M derived: sum of 2 quarters · filed 2021-11-02 | $25.30M 10-Q · filed 2021-11-02 | $32.69M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $9.49M 10-Q · filed 2021-07-30 | $17.19M 10-Q · filed 2021-07-30 | $24.58M derived: sum of 3 quarters · filed 2022-02-16 | $31.67M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $7.69M 10-Q · filed 2021-05-04 | $15.09M derived: sum of 2 quarters · filed 2022-02-16 | $22.18M derived: sum of 3 quarters · filed 2022-02-16 | $30.36M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $14.48M derived: sum of 2 quarters · filed 2022-02-16 | $22.67M derived: sum of 3 quarters · filed 2022-02-16 | $31.05M 10-K · filed 2022-02-16 |
| 2019-09-30 | $7.09M 10-Q · filed 2020-10-29 | $15.28M derived: sum of 2 quarters · filed 2020-10-29 | $23.66M 10-Q · filed 2020-10-29 | $32.22M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $8.19M 10-Q · filed 2020-07-31 | $16.57M 10-Q · filed 2020-07-31 | $25.13M derived: sum of 3 quarters · filed 2021-02-12 | $33.59M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $8.39M 10-Q · filed 2020-04-30 | $16.95M derived: sum of 2 quarters · filed 2021-02-12 | $25.40M derived: sum of 3 quarters · filed 2021-02-12 | $33.86M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $17.01M derived: sum of 2 quarters · filed 2021-02-12 | $25.47M derived: sum of 3 quarters · filed 2021-02-12 | $34.74M 10-K · filed 2021-02-12 |
| 2018-09-30 | $8.45M 10-Q · filed 2019-10-31 | $16.91M derived: sum of 2 quarters · filed 2019-10-31 | $26.18M 10-Q · filed 2019-10-31 | $35.90M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $8.46M 10-Q · filed 2019-08-01 | $17.73M 10-Q · filed 2019-08-01 | $27.45M derived: sum of 3 quarters · filed 2020-02-14 | $37.21M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $9.27M 10-Q · filed 2019-05-01 | $18.99M derived: sum of 2 quarters · filed 2020-02-14 | $28.75M derived: sum of 3 quarters · filed 2020-02-14 | $37.91M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $9.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $19.48M derived: sum of 2 quarters · filed 2020-02-14 | $28.64M derived: sum of 3 quarters · filed 2020-02-14 | $37.23M 10-K · filed 2020-02-14 |
| 2017-09-30 | $9.76M 10-Q · filed 2018-11-01 | $18.92M derived: sum of 2 quarters · filed 2018-11-01 | $27.51M 10-Q · filed 2018-11-01 | $35.26M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $9.15M 10-Q · filed 2018-08-01 | $17.74M 10-Q · filed 2018-08-01 | $25.50M derived: sum of 3 quarters · filed 2019-02-15 | $33.28M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $8.59M 10-Q · filed 2018-05-04 | $16.34M derived: sum of 2 quarters · filed 2019-02-15 | $24.13M derived: sum of 3 quarters · filed 2019-02-15 | $32.33M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $15.54M derived: sum of 2 quarters · filed 2019-02-15 | $23.75M derived: sum of 3 quarters · filed 2019-02-15 | $32.05M 10-K · filed 2019-02-15 |
| 2016-09-30 | $7.79M 10-Q · filed 2017-10-31 | $15.99M derived: sum of 2 quarters · filed 2017-10-31 | $24.29M 10-Q · filed 2017-10-31 | $32.22M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $8.20M 10-Q · filed 2017-08-01 | $16.51M 10-Q · filed 2017-08-01 | $24.43M derived: sum of 3 quarters · filed 2018-02-16 | $32.18M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $8.30M 10-Q · filed 2017-04-28 | $16.23M derived: sum of 2 quarters · filed 2018-02-16 | $23.98M derived: sum of 3 quarters · filed 2018-02-16 | $31.24M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $7.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $15.68M derived: sum of 2 quarters · filed 2018-02-16 | $22.93M derived: sum of 3 quarters · filed 2018-02-16 | $29.24M 10-K · filed 2018-02-16 |
| 2015-09-30 | $7.75M 10-Q · filed 2016-11-01 | $15.01M derived: sum of 2 quarters · filed 2016-11-01 | $21.31M 10-Q · filed 2016-11-01 | $26.71M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $7.26M 10-Q · filed 2016-08-02 | $13.56M 10-Q · filed 2016-08-02 | $18.96M derived: sum of 3 quarters · filed 2017-02-17 | $23.25M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $6.30M 10-Q · filed 2016-04-29 | $11.70M derived: sum of 2 quarters · filed 2017-02-17 | $15.99M derived: sum of 3 quarters · filed 2017-02-17 | $18.96M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $9.69M derived: sum of 2 quarters · filed 2017-02-17 | $12.65M derived: sum of 3 quarters · filed 2017-02-17 | $15.43M 10-K · filed 2017-02-17 |
| 2014-09-30 | $4.29M 10-Q · filed 2015-10-28 | $7.26M derived: sum of 2 quarters · filed 2015-10-28 | $10.03M 10-Q · filed 2015-10-28 | $11.94M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $2.96M 10-Q · filed 2015-07-30 | $5.74M 10-Q · filed 2015-07-30 | $7.65M derived: sum of 3 quarters · filed 2016-02-17 | $9.11M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $2.77M 10-Q · filed 2015-04-28 | $4.68M derived: sum of 2 quarters · filed 2016-02-17 | $6.15M derived: sum of 3 quarters · filed 2016-02-17 | $7.33M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $3.37M derived: sum of 2 quarters · filed 2016-02-17 | $4.55M derived: sum of 3 quarters · filed 2016-02-17 | $5.39M 10-K · filed 2016-02-17 |
| 2013-09-30 | $1.46M 10-Q · filed 2014-10-24 | $2.64M derived: sum of 2 quarters · filed 2014-10-24 | $3.48M 10-Q · filed 2014-10-24 | $4.33M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $1.18M 10-Q · filed 2014-07-25 | $2.01M 10-Q · filed 2014-07-25 | $2.87M derived: sum of 3 quarters · filed 2015-02-17 | $3.74M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $835.00K 10-Q · filed 2014-04-25 | $1.69M derived: sum of 2 quarters · filed 2015-02-17 | $2.56M derived: sum of 3 quarters · filed 2015-02-17 | $3.49M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $856.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $1.73M derived: sum of 2 quarters · filed 2015-02-17 | $2.65M derived: sum of 3 quarters · filed 2015-02-17 | $3.85M 10-K · filed 2015-02-17 |
| 2012-09-30 | $873.00K 10-Q · filed 2013-10-22 | $1.80M derived: sum of 2 quarters · filed 2013-10-22 | $2.99M 10-Q · filed 2013-10-22 | $4.10M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $926.00K 10-Q · filed 2013-07-23 | $2.12M 10-Q · filed 2013-07-23 | $3.23M derived: sum of 3 quarters · filed 2014-02-18 | $4.16M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $1.19M 10-Q · filed 2013-04-23 | $2.30M derived: sum of 2 quarters · filed 2014-02-18 | $3.23M derived: sum of 3 quarters · filed 2014-02-18 | $4.01M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $2.04M derived: sum of 2 quarters · filed 2014-02-18 | $2.82M derived: sum of 3 quarters · filed 2014-02-18 | $3.55M 10-K · filed 2014-02-18 |
| 2011-09-30 | $928.00K 10-Q · filed 2012-10-19 | $1.71M derived: sum of 2 quarters · filed 2012-10-19 | $2.44M 10-Q · filed 2012-10-19 | $3.11M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $782.00K 10-Q · filed 2012-07-20 | $1.51M 10-Q · filed 2012-07-20 | $2.18M derived: sum of 3 quarters · filed 2013-02-19 | $2.87M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $728.00K 10-Q · filed 2012-04-20 | $1.40M derived: sum of 2 quarters · filed 2013-02-19 | $2.09M derived: sum of 3 quarters · filed 2013-02-19 | $2.78M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $1.36M derived: sum of 2 quarters · filed 2013-02-19 | $2.05M derived: sum of 3 quarters · filed 2013-02-19 | $2.42M 10-K · filed 2013-02-19 |
| 2010-09-30 | $687.00K 10-Q · filed 2011-10-21 | $1.38M derived: sum of 2 quarters · filed 2011-10-21 | $1.74M 10-Q · filed 2011-10-21 | $2.12M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $689.00K 10-Q · filed 2011-07-22 | $1.05M 10-Q · filed 2011-07-22 | $1.44M derived: sum of 3 quarters · filed 2012-02-17 | $1.87M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $365.00K 10-Q · filed 2011-04-21 | $746.00K derived: sum of 2 quarters · filed 2012-02-17 | $1.18M derived: sum of 3 quarters · filed 2012-02-17 | $1.64M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $817.00K derived: sum of 2 quarters · filed 2012-02-17 | $1.28M derived: sum of 3 quarters · filed 2012-02-17 | $1.92M 10-K · filed 2012-02-17 |
| 2009-09-30 | $436.00K 10-Q · filed 2010-10-22 | $895.00K derived: sum of 2 quarters · filed 2010-10-22 | $1.53M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $459.00K 10-Q · filed 2010-07-23 | $1.10M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $4.59M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |